The emerging role of liquid biopsy in oral squamous cell carcinoma detection: advantages and challenges

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. 2021;71(3):209–249. doi: 10.3322/caac.21660
   Google Scholar
• Sarode G, Maniyar N, Sarode SC, et al. Epidemiologic aspects of oral cancer. 2020;66(12):100988. doi: 10.1016/j.disamonth.2020.100988
   Google Scholar
• Chow L, Longo DL. Head and neck cancer. N Engl J Med. 2020;382(1):60–72. doi: 10.1056/NEJMra1715715
   PubMed Web of Science ®Google Scholar
• Chi AC, Day TA, Neville B. Oral cavity and oropharyngeal squamous cell carcinoma—an update. 2015;65(5):401–421.
   Google Scholar
• Chattopadhyay I, Verma M, Panda M. treatment. Role of oral microbiome signatures in diagnosis and prognosis of oral cancer. 2019;18: 1533033819867354. doi: 10.1177/1533033819867354
   Google Scholar
• Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA: Cancer J. 2011;61(2):69–90.
   PubMed Web of Science ®Google Scholar
• Petersen P. Oral cancer prevention and control–the approach of the. World Health Org. 2009;45(4–5):454–460. doi: 10.1016/j.oraloncology.2008.05.023
   Google Scholar
• Gupta B, Johnson N, Li Y. Systematic review and meta-analysis of association of smokeless tobacco and of betel quid without tobacco with incidence of oral cancer in South Asia and the Pacific. PLOS ONE. 2014;9(11):e113385. doi: 10.1371/journal.pone.0113385
   PubMed Web of Science ®Google Scholar
• Shaikh MH, McMillan NA, Johnson N. HPV-associated head and neck cancers in the Asia Pacific: a critical literature review & meta-analysis. 2015;39(6):923–938.
   Google Scholar
• García-Martín JM, Varela-Centelles P, González M, et al. Epidemiology of oral cancer. Detect Oral Cancer. 2019:81–93.
   Google Scholar
• Wyss A, Hashibe M, Chuang S-C, et al. Cigarette, cigar, and pipe smoking and the risk of head and neck cancers: pooled analysis in the international head and neck cancer epidemiology consortium. Am J Epidemiol. 2013;178(5):679–690. doi: 10.1093/aje/kwt029
   PubMed Web of Science ®Google Scholar
• Sarode SC, Sarode GS, Tupkari J. Oral potentially malignant disorders: precising the definition. Oral Oncol. 2012;48(9):759–760.
   PubMed Web of Science ®Google Scholar
• Naito Y, Honda K. Liquid biopsy for oral cancer diagnosis: recent advances and challenges. 2023;13(2):303. doi: 10.3390/jpm13020303
   Google Scholar
• D’Souza G, Kreimer AR, Viscidi R, et al. Case–control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356(19):1944–1956. doi: 10.1056/NEJMoa065497
   PubMed Web of Science ®Google Scholar
• Walsh T, Liu JL, Brocklehurst P, et al. Clinical assessment to screen for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults. Cochrane Database Syst Rev. 2013;11. doi: 10.1002/14651858.CD010173.pub2
   Google Scholar
• Omar EJH. medicine f. Current concepts and future of noninvasive procedures for diagnosing oral squamous cell carcinoma-a systematic review. 2015;11(1): 1–27. doi: 10.1186/s13005-015-0063-z
   Google Scholar
• Cristofanilli M, Budd GT, Ellis MJ, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004;351(8):781–791. doi: 10.1056/NEJMoa040766
   PubMed Web of Science ®Google Scholar
• Chae YK, Davis AA, Carneiro BA, et al. Concordance between genomic alterations assessed by next-generation sequencing in tumor tissue or circulating cell-free DNA. Oncotarget. 2016;7(40):65364. doi: 10.18632/oncotarget.11692
   PubMed Web of Science ®Google Scholar
• Siravegna G, Marsoni S, Siena S, et al. Integrating liquid biopsies into the management of cancer. Nat Rev Clin Oncol. 2017;14(9):531–548.
   PubMed Web of Science ®Google Scholar
• Crowley E, Di Nicolantonio F, Loupakis F, et al. Liquid biopsy: monitoring cancer-genetics in the blood. Nat Rev Clin Oncol. 2013;10(8):472–484.
   PubMed Web of Science ®Google Scholar
• Zhang X, BJOD L. Updates of liquid biopsy in oral cancer and multiomics analysis. Oral Dis. 2023;29(1):51–61. doi: 10.1111/odi.14064
   PubMed Web of Science ®Google Scholar
• Patel A, Patel S, Patel P, et al. Saliva based liquid biopsies in head and neck cancer: how far are we from the clinic? 2022;12:828434. doi: 10.3389/fonc.2022.828434
   Google Scholar
• Schwarzenbach H, Hoon DS, Pantel KJNRC. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer. 2011;11(6):426–437.
   PubMed Web of Science ®Google Scholar
• Ashworth TJAMJ. A case of cancer in which cells similar to those in the tumours were seen in the blood after death. Aust Med J. 1869;14:146.
   Google Scholar
• Potdar PD, Lotey NKJJCMT. Role of circulating tumor cells in future diagnosis and therapy of cancer. 2015;1(2):44. doi: 10.4103/2394-4722.158803
   Google Scholar
• Castro-Giner F, Aceto NJGM. Tracking cancer progression: from circulating tumor cells to metastasis. Genome Med. 2020;12(1):1–12. doi: 10.1186/s13073-020-00728-3
   Web of Science ®Google Scholar
• Economopoulou P, Kotsantis I, Kyrodimos E, et al. Liquid biopsy: an emerging prognostic and predictive tool in head and neck squamous cell carcinoma (HNSCC). Focus on circulating tumor cells (CTCs). 2017;74:83–89. doi: 10.1016/j.oraloncology.2017.09.012
   Google Scholar
• Kaldjian EP, Ramirez AB, Sun Y, et al. The RareCyte® platform for next‐generation analysis of circulating tumor cells. Cytometry Part A. 2018;93(12):1220–1225. doi: 10.1002/cyto.a.23619
   PubMedGoogle Scholar
• Langley RR, Fidler I. The seed and soil hypothesis revisited—The role of tumor‐stroma interactions in metastasis to different organs. 2011;128(11):2527–2535.
   Google Scholar
• Méhes G, Witt A, Kubista E, et al. Circulating breast cancer cells are frequently apoptotic. Am J Pathol. 2001;159(1):17–20.
   PubMed Web of Science ®Google Scholar
• Hanna NJCR. Inhibition of experimental tumor metastasis by selective activation of natural killer cells. Cancer Res. 1982;42(4):1337–1342.
   PubMed Web of Science ®Google Scholar
• Kulasinghe A, Perry C, Jovanovic L, et al. Circulating tumour cells in metastatic head and neck cancers. Int J Cancer Res. 2015;136(11):2515–2523.
   PubMed Web of Science ®Google Scholar
• Watanabe SJC. The metastasizability of tumor cells. Cancer. 1954;7(2):215–223. doi: 10.1002/1097-0142(195403)7:2<215:AID-CNCR2820070203>3.0.CO;2-6
   PubMed Web of Science ®Google Scholar
• Cho EH, Wendel M, Luttgen M, et al. Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors. Phys Biol. 2012;9(1):016001. doi: 10.1088/1478-3975/9/1/016001
   PubMed Web of Science ®Google Scholar
• Sharma D, Brummel‐Ziedins KE, Bouchard BA, et al. Platelets in tumor progression: a host factor that offers multiple potential targets in the treatment of cancer. J Cell Physiol. 2014;229(8):1005–1015.
   PubMed Web of Science ®Google Scholar
• Allard WJ, Matera J, Miller MC, et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res. 2004;10(20):6897–6904. doi: 10.1158/1078-0432.CCR-04-0378
   PubMed Web of Science ®Google Scholar
• Au SH, Storey BD, Moore JC, et al. Clusters of circulating tumor cells traverse capillary-sized vessels. Proc Nat Acad Sci. 2016;113(18):4947–4952. doi: 10.1073/pnas.1524448113
   PubMed Web of Science ®Google Scholar
• Yousefi M, Ghaffari P, Nosrati R, et al. Prognostic and therapeutic significance of circulating tumor cells in patients with lung cancer. Cell Oncol. 2020;43(1):31–49. doi: 10.1007/s13402-019-00470-y
   PubMed Web of Science ®Google Scholar
• Chen Q, Zou J, He Y, et al. A narrative review of circulating tumor cells clusters: a key morphology of cancer cells in circulation promote hematogenous metastasis. Front Oncol. 2022;12:944487. doi: 10.3389/fonc.2022.944487
   PubMed Web of Science ®Google Scholar
• Partridge M, Brakenhoff R, Phillips E, et al. Detection of rare disseminated tumor cells identifies head and neck cancer patients at risk of treatment failure. Clin Cancer Res. 2003;9(14):5287–5294.
   PubMed Web of Science ®Google Scholar
• Wang X, Wang L, Lin H, et al. Research progress of CTC, ctDNA, and EVs in cancer liquid biopsy. Front Oncol. 2024;14:14. doi: 10.3389/fonc.2024.1303335
   Web of Science ®Google Scholar
• Pantel K, Brakenhoff RH, Brandt BJNRC. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer. 2008;8(5):329–340. doi: 10.1038/nrc2375
   PubMed Web of Science ®Google Scholar
• Satelli A, Brownlee Z, Mitra A, et al. Circulating tumor cell enumeration with a combination of epithelial cell adhesion molecule– and cell-surface vimentin–based methods for monitoring breast cancer therapeutic response. Clin Chem. 2015;61(1):259–266. doi: 10.1373/clinchem.2014.228122
   PubMed Web of Science ®Google Scholar
• Wu Y, Deighan CJ, Miller BL, et al. Isolation and analysis of rare cells in the blood of cancer patients using a negative depletion methodology. Methods. 2013;64(2):169–182. doi: 10.1016/j.ymeth.2013.09.006
   PubMed Web of Science ®Google Scholar
• Zscheppang K, Kurth I, Wachtel N, et al. Efficacy of beta1 integrin and EGFR targeting in sphere-forming human head and neck cancer cells. J Cancer. 2016;7(6):736.
   PubMed Web of Science ®Google Scholar
• Gabriel MT, Calleja LR, Chalopin A, et al. Circulating tumor cells: a review of non–EpCAM-based approaches for cell enrichment and isolation. Clin Chem. 2016;62(4):571–581.
   PubMed Web of Science ®Google Scholar
• Jacob K, Sollier C, Jabado N. Circulating tumor cells: detection, molecular profiling and future prospects. Expert Rev Proteomics. 2007;4(6):741–756.
   PubMed Web of Science ®Google Scholar
• Danova M, Torchio M, Mazzini G. Isolation of rare circulating tumor cells in cancer patients: technical aspects and clinical implications. Expert Rev Mol Diagn. 2011;11(5):473–485.
   PubMed Web of Science ®Google Scholar
• Kong L, Birkeland ACJC. Liquid biopsies in head and neck cancer: current state and future challenges. Cancers. 2021;13(8):1874.
   PubMed Web of Science ®Google Scholar
• Deng G, Herrler M, Burgess D, et al. Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients. Breast Cancer Res. 2008;10(4):1–11. doi: 10.1186/bcr2131
   Web of Science ®Google Scholar
• Pamme N. On-chip bioanalysis with magnetic particles. Curr Opin Chem Biol. 2012;16(3–4):436–443.
   PubMed Web of Science ®Google Scholar
• Alix-Panabières C, Pantel KJNRC. Challenges in circulating tumour cell research. Nat Rev Cancer. 2014;14(9):623–631.
   PubMed Web of Science ®Google Scholar
• Bates M, Mohamed BM, Ward MP, et al. Circulating tumour cells: the good, the bad and the ugly. Biochimica Et Biophysica Acta (BBA) - Reviews On Cancer. 2023;1878(2):188863. doi: 10.1016/j.bbcan.2023.188863
   PubMed Web of Science ®Google Scholar
• Mandel P, Metais P. [Nuclear Acids in Human Blood Plasma], Comptes rendus des seances de la societe de biologie et de ses filiales. 1948;142(3–4):241–243.
   Google Scholar
• Leon S, Shapiro B, Sklaroff D, et al. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res. 1977;37(3):646–650.
   PubMed Web of Science ®Google Scholar
• Stroun M, Anker P, Maurice P, et al. Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology. 1989;46(5):318–322. doi: 10.1159/000226740
   PubMed Web of Science ®Google Scholar
• Lauritano D, Oberti L, Gabrione F, et al. Liquid biopsy in head and neck squamous cell carcinoma: prognostic significance of circulating tumor cells and circulating tumor DNA. A systematic review. Oral Oncol. 2019;97:7–17. doi: 10.1016/j.oraloncology.2019.07.003
   PubMed Web of Science ®Google Scholar
• Jung A, Kirchner TJDÄI. Liquid biopsy in tumor genetic diagnosis. Deutsches Ärzteblatt International. 2018;115(10):169.
   PubMed Web of Science ®Google Scholar
• Cheng F, Su L, Qian CJO. Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer. Oncotarget. 2016;7(30):48832. doi: 10.18632/oncotarget.9453
   PubMedGoogle Scholar
• Jahr S, Hentze H, Englisch S, et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res. 2001;61(4):1659–1665.
   PubMed Web of Science ®Google Scholar
• Yang W-Y, Feng L-F, Meng X, et al. Liquid biopsy in head and neck squamous cell carcinoma: circulating tumor cells, circulating tumor DNA, and exosomes. 2020;20(12):1213–1227. doi: 10.1080/14737159.2020.1855977
   Google Scholar
• Bettegowda C, Sausen M, Leary RJ, et al. Detection of circulating tumor DNA in early-and late-stage human malignancies. Sci Transl Med. 2014;6(224):ra224224–ra224224.
   Web of Science ®Google Scholar
• Haber DA, Velculescu V. Blood-based analyses of cancer: circulating tumor cells and circulating tumor DNA. Cancer Discovery. 2014;4(6):650–661. doi: 10.1158/2159-8290.CD-13-1014
   PubMed Web of Science ®Google Scholar
• Schröck A, Leisse A, de Vos L, et al. Free-circulating methylated DNA in blood for diagnosis, staging, prognosis, and monitoring of head and neck squamous cell carcinoma patients: an observational prospective cohort study. 2017;63(7):1288–1296. doi: 10.1373/clinchem.2016.270207
   Google Scholar
• Warton K, Samimi G. Methylation of cell-free circulating DNA in the diagnosis of cancer. 2015;2:13. doi: 10.3389/fmolb.2015.00013
   Google Scholar
• Dietrich D, Jung M, Puetzer S, et al. Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant and malignant pleural effusions. PLOS ONE. 2013;8(12):e84225. doi: 10.1371/journal.pone.0084225
   PubMed Web of Science ®Google Scholar
• Jung M, Pützer S, Gevensleben H, et al. Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant, and malignant ascites. Clin epigenetics. 2016;8(1):1–13. doi: 10.1186/s13148-016-0192-7
   PubMedGoogle Scholar
• Mydlarz WK, Hennessey PT, Wang H, et al. neck. Serum biomarkers for detection of head and neck squamous cell carcinoma. 2016;38(1):9–14. doi: 10.1002/hed.23842
   Google Scholar
• Sabharwal A, Middleton M. Exploiting the role of O6-methylguanine-DNA-methyltransferase (MGMT) in cancer therapy. Curr Opin Pharmacol. 2006;6(4):355–363.
   PubMed Web of Science ®Google Scholar
• Misawa K, Yamada S, Mima M, et al. Long interspersed nuclear element 1 hypomethylation has novel prognostic value and potential utility in liquid biopsy for oral cavity cancer. Biomark Res. 2020;8(1):1–10. doi: 10.1186/s40364-020-00235-y
   PubMed Web of Science ®Google Scholar
• Basnet S, Zhang Z-Y, Liao W-Q, et al. The prognostic value of circulating cell-free DNA in colorectal cancer: a meta-analysis. J Cancer. 2016;7(9):1105.
   PubMed Web of Science ®Google Scholar
• Ocana A, Díez-González L, García-Olmo DC, et al. Circulating DNA and survival in solid tumors. Cancer Epidemiol Biomarkers Prev. 2016;25(2):399–406. doi: 10.1158/1055-9965.EPI-15-0893
   PubMed Web of Science ®Google Scholar
• Liu W, Ji T, Zhang C, et al. Cell-free DNA hypermethylated genes may have a limited role in cancer screening but a potential role in risk assessment of head and neck cancer. Oral Oncol. 2022;134:106129.
   PubMed Web of Science ®Google Scholar
• Griffiths-Jones S, Grocock RJ, Van Dongen S, et al. Enright AJJNar. miRbase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 2006;34(suppl_1):D140–D144. doi: 10.1093/nar/gkj112
   PubMedGoogle Scholar
• Friedman RC, Farh K-H, Burge CB, et al. Most mammalian mRnas are conserved targets of microRnas. Genome Res. 2009;19(1):92–105. doi: 10.1101/gr.082701.108
   PubMed Web of Science ®Google Scholar
• Javidi MA, Ahmadi AH, Bakhshinejad B, et al. Cell-free microRnas as cancer biomarkers: the odyssey of miRnas through body fluids. Med Oncol. 2014;31(12):1–11. doi: 10.1007/s12032-014-0295-y
   Web of Science ®Google Scholar
• Wang K, Zhang S, Weber J, et al. Export of microRnas and microRNA-protective protein by mammalian cells. Nucleic Acids Res. 2010;38(20):7248–7259.
   PubMed Web of Science ®Google Scholar
• He Y, Lin J, Kong D, et al. Current state of circulating microRnas as cancer biomarkers. Clin Chem. 2015;61(9):1138–1155. doi: 10.1373/clinchem.2015.241190
   PubMed Web of Science ®Google Scholar
• Hyun K-A, Kim J, Gwak H, et al. Isolation and enrichment of circulating biomarkers for cancer screening, detection, and diagnostics. Analyst. 2016;141(2):382–392.
   PubMed Web of Science ®Google Scholar
• Chakraborty C, Das SJTB. Profiling cell-free and circulating miRNA: a clinical diagnostic tool for different cancers. Tumor Biolog. 2016;37(5):5705–5714.
   PubMedGoogle Scholar
• Jacobsen N, Andreasen D, Mouritzen P. Protocols. Profiling microRnas by real-time PCR. MicroRNAs in Development: Methods and Protocols. 2011;732:39–54.
   Google Scholar
• D’Alessandra Y, Valerio V, Moschetta D, et al. Extraction-free absolute quantification of circulating miRnas by chip-based digital PCR. Biomedicines. 2022;10(6):1354. doi: 10.3390/biomedicines10061354
   PubMed Web of Science ®Google Scholar
• Aggarwal S, Sharma SC, Das SNJCCA. Galectin-1 and galectin-3: plausible tumour markers for oral squamous cell carcinoma and suitable targets for screening high-risk population. 2015;442:13–21. doi: 10.1016/j.cca.2014.12.038
   Google Scholar
• Bu J, Bu X, Liu B, et al. Increased expression of tissue/salivary transgelin mrna predicts poor prognosis in patients with oral squamous cell carcinoma (OSCC) surgery. Med Sci Monit. 2015;21:2275. doi: 10.12659/MSM.893925
   PubMed Web of Science ®Google Scholar
• Eissa S, Matboli M, Essawy NO, et al. Rapid detection of urinary long non-coding RNA urothelial carcinoma associated one using a PCR-free nanoparticle-based assay. Biomarkers. 2015;20(3):212–217. doi: 10.3109/1354750X.2015.1062918
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhao L, Wang Y-X, et al. Long non-coding RNA HOTTIP is correlated with progression and prognosis in tongue squamous cell carcinoma. Tumor Biol. 2015;36(11):8805–8809. doi: 10.1007/s13277-015-3645-2
   PubMedGoogle Scholar
• Gezer U, Özgür E, Cetinkaya M, et al. Long non‐coding RNAs with low expression levels in cells are enriched in secreted exosomes. Cell Biol Int. 2014;38(9):1076–1079.
   PubMed Web of Science ®Google Scholar
• Tang H, Wu Z, Zhang J, et al. Salivary lncRNA as a potential marker for oral squamous cell carcinoma diagnosis. Mol Med Rep. 2013;7(3):761–766. doi: 10.3892/mmr.2012.1254
   PubMed Web of Science ®Google Scholar
• Zhou X, Yin C, Dang Y, et al. Identification of the long non-coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer. Sci Rep. 2015;5(1):11516.
   PubMedGoogle Scholar
• Feng Y, Hu X, Zhang Y, et al. Methods for the study of long noncoding RNA in cancer cell signaling. Methods Mol Biol. 2014;1165:115–143.
   PubMedGoogle Scholar
• Wojdacz TK, Dobrovic A, Algar E. Rapid detection of methylation change at H19 in human imprinting disorders using methylation‐sensitive high‐resolution melting. Hum Mutat. 2008;29(10):1255–1260.
   PubMed Web of Science ®Google Scholar
• Dodd DW, Gagnon KT, Corey D. Digital quantitation of potential therapeutic target RNAs. Nucleic Acid Ther. 2013;23(3):188–194.
   PubMed Web of Science ®Google Scholar
• Wong T-S, Liu X-B, Wong B-H, et al. Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res. 2008;14(9):2588–2592. doi: 10.1158/1078-0432.CCR-07-0666
   PubMed Web of Science ®Google Scholar
• Lin S-C, Liu C-J, Lin J-A, et al. Chang K-WJOo. miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis. Oral Oncol. 2010;46(3):204–208. doi: 10.1016/j.oraloncology.2009.12.005
   PubMed Web of Science ®Google Scholar
• Hung P-S, Liu C-J, Chou C-S, et al. miR-146a enhances the oncogenicity of oral carcinoma by concomitant targeting of the IRAK1, TRAF6 and NUMB genes. PLOS ONE. 2013;8(11):e79926. doi: 10.1371/journal.pone.0079926
   PubMed Web of Science ®Google Scholar
• Ren W, Qiang C, Gao L, et al. Circulating microRNA-21 (MIR-21) and phosphatase and tensin homolog (PTEN) are promising novel biomarkers for detection of oral squamous cell carcinoma. Biomarkers. 2014;19(7):590–596. doi: 10.3109/1354750X.2014.955059
   PubMed Web of Science ®Google Scholar
• Wang L-L, Li H-X, Yang Y-Y, et al. MiR-31 is a potential biomarker for diagnosis of head and neck squamous cell carcinoma. Intern J Clin Exp Path. 2018;11(9):4339.
   PubMed Web of Science ®Google Scholar
• Sun L, Liu L, Fu H, et al. Shi YJMsmimjoe, research c. Association of decreased expression of serum miR-9 with poor prognosis of oral squamous cell carcinoma patients. Med Sci Monit. 2016;22:289. doi: 10.12659/MSM.895683
   PubMed Web of Science ®Google Scholar
• Lu Y-C, Chang J-C, Huang Y-C, et al. Combined determination of circulating miR-196a and miR-196b levels produces high sensitivity and specificity for early detection of oral cancer. Clin Biochem. 2015;48(3):115–121. doi: 10.1016/j.clinbiochem.2014.11.020
   PubMed Web of Science ®Google Scholar
• Chang Y-A, Weng S-L, Yang S-F, et al. A three–microRNA signature as a potential biomarker for the early detection of oral cancer. Int j mole sci. 2018;19(3):758.
   PubMed Web of Science ®Google Scholar
• Costa-Silva B, Aiello NM, Ocean AJ, et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol. 2015;17(6):816–826. doi: 10.1038/ncb3169
   PubMed Web of Science ®Google Scholar
• Peinado H, Zhang H, Matei IR, et al. Pre-metastatic niches: organ-specific homes for metastases. Nat Rev Cancer. 2017;17(5):302–317. doi: 10.1038/nrc.2017.6
   PubMed Web of Science ®Google Scholar
• Peinado H, Alečković M, Lavotshkin S, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nature Med. 2012;18(6):883–891. doi: 10.1038/nm.2753
   PubMed Web of Science ®Google Scholar
• Tkach M, Théry CJC. Communication by extracellular vesicles: where we are and where we need to go. Cell. 2016;164(6):1226–1232. doi: 10.1016/j.cell.2016.01.043
   PubMed Web of Science ®Google Scholar
• Xu R, Rai A, Chen M, et al. Extracellular vesicles in cancer—implications for future improvements in cancer care. 2018;15(10):617–638.
   Google Scholar
• Colombo M, Moita C, Van Niel G, et al. Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles. J Cell Sci. 2013;126(24):5553–5565. doi: 10.1242/jcs.128868
   PubMed Web of Science ®Google Scholar
• Trajkovic K, Hsu C, Chiantia S, et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science. 2008;319(5867):1244–1247. doi: 10.1126/science.1153124
   PubMed Web of Science ®Google Scholar
• Jiang N, Pan J, Fang S, et al. Liquid biopsy: circulating exosomal long noncoding RNAs in cancer. Clin Chim Acta. 2019;495:331–337. doi: 10.1016/j.cca.2019.04.082
   PubMed Web of Science ®Google Scholar
• Ludwig S, Floros T, Theodoraki M-N, et al. Suppression of lymphocyte functions by plasma exosomes correlates with disease activity in patients with head and neck cancer. Clin Cancer Res. 2017;23(16):4843–4854. doi: 10.1158/1078-0432.CCR-16-2819
   PubMed Web of Science ®Google Scholar
• Languino LR, Singh A, Prisco M, et al. Exosome-mediated transfer from the tumor microenvironment increases TGFβ signaling in squamous cell carcinoma. Am J Transl Res. 2016;8(5):2432.
   PubMed Web of Science ®Google Scholar
• Park JE, Tan HS, Datta A, et al. Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes. Mol Cell Proteomics. 2010;9(6):1085–1099. doi: 10.1074/mcp.M900381-MCP200
   PubMed Web of Science ®Google Scholar
• Li L, Li C, Wang S, et al. Exosomes derived from hypoxic oral squamous cell carcinoma cells deliver miR-21 to normoxic cells to elicit a prometastatic phenotype. Cancer Res. 2016;76(7):1770–1780. doi: 10.1158/0008-5472.CAN-15-1625
   PubMed Web of Science ®Google Scholar
• Turchinovich A, Weiz L, Langheinz A, et al. Characterization of extracellular circulating microRNA. 2011;39(16):7223–7233.
   Google Scholar
• Li Y-Y, Tao Y-W, Gao S, et al. Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p. EBioMed. 2018;36:209–220. doi: 10.1016/j.ebiom.2018.09.006
   PubMed Web of Science ®Google Scholar
• Rodríguez Zorrilla S, Pérez-Sayans M, Fais S, et al. A pilot clinical study on the prognostic relevance of plasmatic exosomes levels in oral squamous cell carcinoma patients. Cancers (Basel). 2019;11(3):429. doi: 10.3390/cancers11030429
   PubMed Web of Science ®Google Scholar
• Li C, Zhou Y, Liu J, et al. Potential markers from serum-purified exosomes for detecting oral squamous cell carcinoma metastasis. Cancer Epidemiol Biomarkers Prev. 2019;28(10):1668–1681. doi: 10.1158/1055-9965.EPI-18-1122
   PubMed Web of Science ®Google Scholar
• Luo Y, Liu F, Guo J, et al. Upregulation of circ_0000199 in circulating exosomes is associated with survival outcome in OSCC. 2020;10(1):13739. doi: 10.1038/s41598-020-70747-y
   Google Scholar
• He T, Guo X, Li X, et al. Plasma-derived exosomal microRNA-130a serves as a noninvasive biomarker for diagnosis and prognosis of oral squamous cell carcinoma. J Oncol. 2021;2021:1–9.
   Web of Science ®Google Scholar
• Fujiwara T, Eguchi T, Sogawa C, et al. Carcinogenic epithelial-mesenchymal transition initiated by oral cancer exosomes is inhibited by anti-EGFR antibody cetuximab. Oral Oncol. 2018;86:251–257. doi: 10.1016/j.oraloncology.2018.09.030
   PubMed Web of Science ®Google Scholar
• Theodoraki M-N, Yerneni SS, Hoffmann TK, et al. Clinical significance of PD-L1+ exosomes in plasma of head and neck cancer patients. 2018;24(4):896–905. doi: 10.1158/1078-0432.CCR-17-2664
   Google Scholar
• Huang Z, Yang X, Huang Y, et al. Saliva–a new opportunity for fluid biopsy. Clin Chem Lab Med. 2023;61(1):4–32. doi: 10.1515/cclm-2022-0793
   PubMed Web of Science ®Google Scholar
• Rodríguez-Molinero J, Del Carmen Migueláñez-Medrán B, Delgado-Somolinos E, et al. Advances in the diagnosis, monitoring, and progression of oral cancer through saliva: an update. Bio Med Res Int. 2022;2022:1–21. doi: 10.1155/2022/2739869
   Google Scholar
• Liao L, Wang J, Ouyang S, et al. Expression and clinical significance of microRNA-1246 in human oral squamous cell carcinoma. Med Sci Monit. 2015;21(776):776–781. doi: 10.12659/MSM.892508
   PubMedGoogle Scholar
• Brinkmann O, Kastratovic DA, Dimitrijevic MV, et al. Oral squamous cell carcinoma detection by salivary biomarkers in a Serbian population. Oral Oncol. 2011;47(1):51–55. doi: 10.1016/j.oraloncology.2010.10.009
   PubMed Web of Science ®Google Scholar
• Bag S, Dutta D, Chaudhary A, et al. NanoLC MALDI MS/MS based quantitative metabolomics reveals the alteration of membrane biogenesis in oral cancer. RSC Adv. 2016;6(67):62420–62433. doi: 10.1039/C6RA07001A
   Web of Science ®Google Scholar
• Rai V, Mukherjee R, Ghosh AK, et al. “Omics” in oral cancer: new approaches for biomarker discovery. Arch Oral Biol. 2018;87:15–34. doi: 10.1016/j.archoralbio.2017.12.003
   PubMed Web of Science ®Google Scholar
• Cristaldi M, Mauceri R, Di Fede O, et al. Salivary biomarkers for oral squamous cell carcinoma diagnosis and follow-up: current status and perspectives. Front physiol. 2019;10:1476. doi: 10.3389/fphys.2019.01476
   PubMed Web of Science ®Google Scholar
• Lee YC, Kim SI, Kwon H, et al. Circulating tumor DNA in the saliva of patients with head and neck cancer: a pilot report. Oral Dis. 2021;27(6):1421–1425.
   PubMed Web of Science ®Google Scholar
• Hyun K-A, Gwak H, Lee J, et al. Salivary exosome and cell-free DNA for cancer detection. Micromachine. 2018;9(7):340.
   PubMed Web of Science ®Google Scholar
• Rosas SLB, Koch W, Carvalho M, et al. Promoter hypermethylation patterns of p16, O 6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer res. 2001;61(3):939–942.
   PubMed Web of Science ®Google Scholar
• Righini CA, de Fraipont F, Timsit J-F, et al. Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence. Clin Cancer Res. 2007;13(4):1179–1185. doi: 10.1158/1078-0432.CCR-06-2027
   PubMed Web of Science ®Google Scholar
• Birknerova N, Mancikova V, Paul ED, et al. Circulating cell-free DNA-based methylation pattern in saliva for early diagnosis of head and neck cancer. Cancers (Basel). 2022;14(19):4882. doi: 10.3390/cancers14194882
   PubMed Web of Science ®Google Scholar
• Rapado-González Ó, López-Cedrún JL, López-López R, et al. Saliva gene promoter hypermethylation as a biomarker in oral cancer. J Clin Med. 2021;10(9):1931. doi: 10.3390/jcm10091931
   PubMed Web of Science ®Google Scholar
• Rettori MM, de Carvalho AC, Bomfim Longo AL, et al. Prognostic significance of TIMP3 hypermethylation in post-treatment salivary rinse from head and neck squamous cell carcinoma patients. Carcinogenesis. 2013;34(1):20–27. doi: 10.1093/carcin/bgs311
   PubMed Web of Science ®Google Scholar
• Langevin SM, Butler RA, Eliot M, et al. Novel DNA methylation targets in oral rinse samples predict survival of patients with oral squamous cell carcinoma. Oral Oncol. 2014;50(11):1072–1080. doi: 10.1016/j.oraloncology.2014.08.015
   PubMed Web of Science ®Google Scholar
• Li Y, Zhou X, St. John M, et al. RNA profiling of cell-free saliva using microarray technology. J dental res. 2004;83(3):199–203.
   PubMed Web of Science ®Google Scholar
• Park NJ, Zhou H, Elashoff D, et al. Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res. 2009;15(17):5473–5477. doi: 10.1158/1078-0432.CCR-09-0736
   PubMed Web of Science ®Google Scholar
• Wiklund ED, Gao S, Hulf T, et al. MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma. PLOS ONE. 2011;6(11):e27840. doi: 10.1371/journal.pone.0027840
   PubMed Web of Science ®Google Scholar
• Momen-Heravi F, Trachtenberg A, Kuo W, et al. Genomewide study of salivary microRnas for detection of oral cancer. J dental res. 2014;93(7_suppl):86S–93S.
   PubMed Web of Science ®Google Scholar
• Duz MB, Karatas OF, Guzel E, et al. Identification of miR-139-5p as a saliva biomarker for tongue squamous cell carcinoma: a pilot study. Cell Oncol. 2016;39(2):187–193. doi: 10.1007/s13402-015-0259-z
   PubMed Web of Science ®Google Scholar
• Yap T, Koo K, Cheng L, et al. Predicting the presence of oral squamous cell carcinoma using commonly dysregulated MicroRNA in oral swirls. Cancer Prev Res. 2018;11(8):491–502. doi: 10.1158/1940-6207.CAPR-17-0409
   PubMed Web of Science ®Google Scholar
• Mehdipour M, Shahidi M, Manifar S, et al. Diagnostic and prognostic relevance of salivary microRNA-21,-125a,-31 and-200a levels in patients with oral lichen planus-a short report. Cell Oncol. 2018;41(3):329–334. doi: 10.1007/s13402-018-0372-x
   Web of Science ®Google Scholar
• Tan J, Xiang L, GJIl X. LncRNA MEG3 suppresses migration and promotes apoptosis by sponging miR‐548d‐3p to modulate JAK–STAT pathway in oral squamous cell carcinoma. IUBMB Life. 2019;71(7):882–890.
   PubMed Web of Science ®Google Scholar
• He L, Ping F, Fan Z, et al. Salivary exosomal miR-24-3p serves as a potential detective biomarker for oral squamous cell carcinoma screening. Biomed Pharmacother. 2020;121:109553. doi: 10.1016/j.biopha.2019.109553
   PubMed Web of Science ®Google Scholar
• Yang YT, Wang YF, Lai JY, et al. Long non-coding RNA UCA 1 contributes to the progression of oral squamous cell carcinoma by regulating the WNT /β-catenin signaling pathway. Cancer Sci. 2016;107(11):1581–1589. doi: 10.1111/cas.13058
   PubMed Web of Science ®Google Scholar
• Fan C, Wang J, Tang Y, et al. Upregulation of long non-coding RNA LOC284454 may serve as a new serum diagnostic biomarker for head and neck cancers. BMC Cancer. 2020;20(1):1–9. doi: 10.1186/s12885-020-07408-w
   Web of Science ®Google Scholar
• Li S, Zhang S, Chen J. C-Myc induced upregulation of long non-coding RNA SNHG16 enhances progression and carcinogenesis in oral squamous cell carcinoma. Cancer gene ther. 2019;26(11–12):400–410.
   PubMed Web of Science ®Google Scholar
• Balakittnen J, Weeramange CE, Wallace DF, et al. Noncoding RNAs in oral cancer. WIREs RNA. 2023;14(3):e1754. doi: 10.1002/wrna.1754
   Google Scholar
• Li G, Wang X, Li C, et al. Piwi-interacting RNA1037 enhances chemoresistance and motility in human oral squamous cell carcinoma cells. 2019;12:10615. doi: 10.2147/OTT.S233322
   Google Scholar
• Fadhil RS, Wei MQ, Nikolarakos D, et al. Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma. PLOS ONE. 2020;15(3):e0221779. doi: 10.1371/journal.pone.0221779
   PubMed Web of Science ®Google Scholar
• Han S, Locke AK, Oaks LA, et al. Nanoparticle-based assay for detection of S100P mRNA using surface-enhanced raman spectroscopy. J Biomed Optic. 2019;24(5):055001–055001.
   PubMed Web of Science ®Google Scholar
• Liu C-J, Chen J-H, Hsia S-M, et al. Salivary LDOC1 is a gender-difference biomarker of oral squamous cell carcinoma. PeerJ. 2019;7:e6732. doi: 10.7717/peerj.6732
   PubMed Web of Science ®Google Scholar
• Liyanage C, Wathupola A, Muraleetharan S, et al. Promoter hypermethylation of tumor-suppressor genes p16INK4a, RASSF1A, TIMP3, and PCQAP/MED15 in salivary DNA as a quadruple biomarker panel for early detection of oral and oropharyngeal cancers. 2019;9(4):148. doi: 10.3390/biom9040148
   Google Scholar
• Oh SY, Kang S-M, Kang SH, et al. Potential salivary mRNA biomarkers for early detection of oral cancer. J clin med. 2020;9(1):243.
   PubMed Web of Science ®Google Scholar
• Ueda S, Hashimoto K, Miyabe S, et al. Salivary NUS1 and RCN1 levels as biomarkers for oral squamous cell carcinoma diagnosis. 2020;34(5):2353–2361. doi: 10.21873/invivo.12048
   Google Scholar
• Ueda S, Goto M, Hashimoto K, et al. Salivary CPLANE1 levels as a biomarker of oral squamous cell carcinoma. Anticancer Res. 2021;41(2):765–772.
   PubMed Web of Science ®Google Scholar
• Cao Y, Green K, Quattlebaum S, et al. Methylated genomic loci encoding microRNA as a biomarker panel in tissue and saliva for head and neck squamous cell carcinoma. 2018;10(1):1–13. doi: 10.1186/s13148-018-0470-7
   Google Scholar
• Chen L, Zhang S, Wu J, et al. circRNA_100290 plays a role in oral cancer by functioning as a sponge of the miR-29 family. 2017;36(32):4551–4561. doi: 10.1038/onc.2017.89
   Google Scholar
• Momen-Heravi F, Bala S. Emerging role of non-coding RNA in oral cancer. 2018;42:134–143. doi: 10.1016/j.cellsig.2017.10.009
   Google Scholar
• Nair S, Tang KD, Kenny L, et al. Salivary exosomes as potential biomarkers in cancer. 2018;84:31–40. doi: 10.1016/j.oraloncology.2018.07.001
   Google Scholar
• Cheshmi B, Cheshomi H. Salivary exosomes: properties, medical applications, and isolation methods. Mol biol repo. 2020;47(8):6295–6307.
   PubMed Web of Science ®Google Scholar
• Zhan C, Yang X, Yin X, et al. Exosomes and other extracellular vesicles in oral and salivary gland cancers. 2020;26(5):865–875. doi: 10.1111/odi.13172
   Google Scholar
• Lai RC, Yeo RWY, Tan KH, et al. Exosomes for drug delivery—a novel application for the mesenchymal stem cell. 2013;31(5):543–551.
   Google Scholar
• Aro K, Kaczor-Urbanowicz K, Carreras-Presas CM. Carreras-presas CMJCoio, head, surgery n. Salivaomics In Oral Cancer. 2019;27(2):91–97. doi:10.1097/MOO.0000000000000502
   Google Scholar
• Ohshiro K, Rosenthal DI, Koomen JM, et al. Pre-analytic saliva processing affect proteomic results and biomarker screening of head and neck squamous carcinoma. Int J Oncol. 2007;30(3):743–749. doi: 10.3892/ijo.30.3.743
   PubMed Web of Science ®Google Scholar
• Hu S, Arellano M, Boontheung P, et al. Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res. 2008;14(19):6246–6252. doi: 10.1158/1078-0432.CCR-07-5037
   PubMed Web of Science ®Google Scholar
• Dowling P, Wormald R, Meleady P, et al. Analysis of the saliva proteome from patients with head and neck squamous cell carcinoma reveals differences in abundance levels of proteins associated with tumour progression and metastasis. J Proteomics. 2008;71(2):168–175.
   PubMed Web of Science ®Google Scholar
• Rai B, Kaur J, Jacobs R, et al. Adenosine deaminase in saliva as a diagnostic marker of squamous cell carcinoma of tongue. Clin Oral Investig. 2011;15(3):347–349. doi: 10.1007/s00784-010-0404-z
   PubMed Web of Science ®Google Scholar
• Elashoff D, Zhou H, Reiss J, et al. Prevalidation of salivary biomarkers for oral cancer detection. Cancer Epidemiol Biomarkers Prev. 2012;21(4):664–672. doi: 10.1158/1055-9965.EPI-11-1093
   PubMed Web of Science ®Google Scholar
• Chen J-H, Wu AT, Bamodu OA, et al. Ovatodiolide suppresses oral cancer malignancy by down-regulating exosomal Mir-21/STAT3/β-catenin cargo and preventing oncogenic transformation of normal gingival fibroblasts. Cancer. 2019;12(1):56.
   Google Scholar
• Winck FV, Prado Ribeiro AC, Ramos Domingues R, et al. Insights into immune responses in oral cancer through proteomic analysis of saliva and salivary extracellular vesicles. Sci Rep. 2015;5(1):16305. doi: 10.1038/srep16305
   PubMedGoogle Scholar
• Sakha S, Muramatsu T, Ueda K, et al. Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma. Scientific Rep. 2016;6(1):38750.
   PubMedGoogle Scholar
• Zlotogorski-Hurvitz A, Dayan D, Chaushu G, et al. Vered MJJocr, oncology c. Morphological and molecular features of oral fluid-derived exosomes: oral cancer patients versus healthy individuals. J Cancer Res Clin Oncol. 2016;142(1):101–110.
   PubMed Web of Science ®Google Scholar
• Ludwig S, Sharma P, Theodoraki M-N, et al. Molecular and functional profiles of exosomes from HPV (+) and HPV (−) head and neck cancer cell lines. Front oncol. 2018;8:445.
   PubMed Web of Science ®Google Scholar
• Li Y, St. John MA, Zhou X, et al. Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res. 2004;10(24):8442–8450. doi: 10.1158/1078-0432.CCR-04-1167
   PubMed Web of Science ®Google Scholar
• Shbeer AM, Robadi I-R. Practice. liquid biopsy holds a promising approach for the early detection of cancer; current information and future perspectives. Pathol Res Pract. 2024;254:155082. doi: 10.1016/j.prp.2023.155082
   PubMed Web of Science ®Google Scholar
• Kim H, Park KUJCR. Association TOJoKC. Clinical circulating tumor dna testing for precision oncology. 2023;55(2):351–366.
   Google Scholar
• Lousada-Fernandez F, Rapado-Gonzalez O, Lopez-Cedrun J-L, et al. Liquid biopsy in oral cancer. Int j mol sci. 2018;19(6):1704.
   PubMed Web of Science ®Google Scholar
• Bidard F-C, Weigelt B, Reis-Filho J. Going with the flow: from circulating tumor cells to DNA. Sci Transl Med. 2013;5(207):ps207214–ps207214.
   Web of Science ®Google Scholar
• Pérez-Ruiz E, Gutiérrez V, Muñoz M, et al. Liquid biopsy as a tool for the characterisation and early detection of the field cancerization effect in patients with oral cavity carcinoma. Biomedicines. 2021;9(10):1478. doi: 10.3390/biomedicines9101478
   PubMed Web of Science ®Google Scholar
• Catelain C, Pailler E, Oulhen M, et al. Detection of gene rearrangements in circulating tumor cells: examples of ALK-, ROS1-, RET-rearrangements in non-small-cell lung cancer and ERG-rearrangements in prostate cancer. Advances in experimental medicine and biology. 2017;994:169–179.
   PubMed Web of Science ®Google Scholar
• Liu K, Chen N, Wei J, et al. Clinical significance of circulating tumor cells in patients with locally advanced head and neck squamous cell carcinoma. Oncol Rep. 2020;43(5):1525–1535.
   PubMed Web of Science ®Google Scholar
• Onidani K, Shoji H, Kakizaki T, et al. Monitoring of cancer patients via next‐generation sequencing of patient‐derived circulating tumor cells and tumor DNA. Cancer Sci. 2019;110(8):2590–2599. doi: 10.1111/cas.14092
   PubMed Web of Science ®Google Scholar
• Afridi WA, Strachan S, Kasetsirikul S, et al. Potential avenues for exosomal isolation and detection methods to enhance small-cell lung cancer analysis. ACS measur sci au. 2023;3(3):143–161. doi: 10.1021/acsmeasuresciau.2c00068
   PubMedGoogle Scholar
• Patel G, Agnihotri TG, Gitte M, et al. Exosomes: a potential diagnostic and treatment modality in the quest for counteracting cancer. Cell Oncol. 2023:1–21.
   Web of Science ®Google Scholar
• Yu D, Li Y, Wang M, et al. Exosomes as a new frontier of cancer liquid biopsy. Mol cancer. 2022;21(1):56. doi: 10.1186/s12943-022-01509-9
   PubMed Web of Science ®Google Scholar
• Yu W, Hurley J, Roberts D, et al. Exosome-based liquid biopsies in cancer: opportunities and challenges. Ann Oncol. 2021;32(4):466–477. doi: 10.1016/j.annonc.2021.01.074
   PubMed Web of Science ®Google Scholar
• Wang Y, Springer S, Mulvey CL, et al. Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas. Sci, trans med. 2015;7(293):ra293104–ra293104. doi: 10.1126/scitranslmed.aaa8507
   Web of Science ®Google Scholar
• Pekin D, Skhiri Y, Baret J-C, et al. Quantitative and sensitive detection of rare mutations using droplet-based microfluidics. Lab Chip. 2011;11(13):2156–2166. doi: 10.1039/c1lc20128j
   PubMed Web of Science ®Google Scholar
• Reedy CR, Price CW, Sniegowski J, et al. Solid phase extraction of DNA from biological samples in a post-based, high surface area poly (methyl methacrylate)(PMMA) microdevice. Lab Chip. 2011;11(9):1603–1611. doi: 10.1039/c0lc00597e
   PubMed Web of Science ®Google Scholar
• Kim S, De Jonghe J, Kulesa AB, et al. High-throughput automated microfluidic sample preparation for accurate microbial genomics. Nat Commun. 2017;8(1):13919. doi: 10.1038/ncomms13919
   PubMedGoogle Scholar
• Carnell-Morris P, Tannetta D, Siupa A, et al. Dragovic RJEvm, protocols. Analysis of extracellular vesicles using fluorescence nanoparticle tracking analysis. Extracell Ves Meth Protoc. 2017;153–173.
   Google Scholar
• Qiu J, Xu J, Zhang K, et al. Refining cancer management using integrated liquid biopsy. Theranostics. 2020;10(5):2374. doi: 10.7150/thno.40677
   PubMed Web of Science ®Google Scholar
• Gu X, He J, GJM J. Combined use of circulating tumor cells and salivary mRNA to detect non–small-cell lung cancer. Medicine. 2020;99(8):e19097.
   PubMed Web of Science ®Google Scholar
• Krug A, Enderle D, Karlovich C, et al. Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma. Ann Oncol. 2018;29(3):700–706. doi: 10.1093/annonc/mdx765
   PubMed Web of Science ®Google Scholar
• Cohen JD, Li L, Wang Y, et al. Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science. 2018;359(6378):926–930. doi: 10.1126/science.aar3247
   PubMed Web of Science ®Google Scholar
• Lone SN, Nisar S, Masoodi T, et al. Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments. Mol cancer. 2022;21(1):79. doi: 10.1186/s12943-022-01543-7
   PubMed Web of Science ®Google Scholar
• Marrugo-Ramírez J, Mir M, Samitier J. Blood-based cancer biomarkers in liquid biopsy: a promising non-invasive alternative to tissue biopsy. Int J Mol Sci. 2018;19(10):2877.
   PubMed Web of Science ®Google Scholar
• Kumar P, Gupta S, Das BCJTO. Saliva as a potential non-invasive liquid biopsy for early and easy diagnosis/prognosis of head and neck cancer. Transl Oncol. 2024;40:101827. doi: 10.1016/j.tranon.2023.101827
   PubMed Web of Science ®Google Scholar
• Chauhan A, Pal A, Sachdeva M, et al. A FACS based novel isolation technique identifies heterogeneous CTCs in Oral Squamous Cell Carcinoma. Front Oncol. 2024;14:1269211.
   PubMed Web of Science ®Google Scholar